. Author manuscript; available in PMC: 2018 Jun 1.

Published in final edited form as: J Nephrol. 2017 Jan 24;30(6):831–839. doi: 10.1007/s40620-016-0374-6

Table 2. Warfarin initiation by CHA₂DS₂-VASc and HAS-BLED risk score categories among older adults (≥65 years) undergoing dialysis with newly diagnosed atrial fibrillation.

CHA₂DS₂-VASc category¹	HAS-BLED category¹			Total

	Low (n = 0)	Intermediate (n = 2824)	High (n = 2906)
Low (n = 10)	0	20.0	0	20.0
Intermediate (n = 896)	0	20.5	15.2	18.5
High (n = 4,824)	0	17.8	12.4	14.9
Total	0	18.3	12.7	15.5

Numbers in the table are cell percentage (%)

Low corresponds to CHA₂DS₂-VASc or HAS-BLED score 1; intermediate corresponds to CHA₂DS₂-VASc or HAS-BLED score 2–3; high corresponds to CHA₂DS₂-VASc 4–9 or HAS-BLED score 4–8

Table 2. Warfarin initiation by CHA2DS2-VASc and HAS-BLED risk score categories among older adults (≥65 years) undergoing dialysis with newly diagnosed atrial fibrillation.

Table 2. Warfarin initiation by CHA₂DS₂-VASc and HAS-BLED risk score categories among older adults (≥65 years) undergoing dialysis with newly diagnosed atrial fibrillation.